Login
Home
Charts
Search
Watchlist
Products

Gujarat Terce Laboratories Ltd

GUJTERC·BSE
₹36.02-4.53%Thu, 24 Sept '26
Industry:Pharma Formulations
Indices:

Gujarat Terce Laboratories Ltd

GUJTERC
BSE
₹36.02
-4.53%
|Thu, 24 Sept '26
SOICxStockScans Reports
Industry
Pharma Formulations
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹28Cr
Close
Close Price
₹36.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
13.14
PS
Price To Sales
0.61
Revenue
Revenue
₹46Cr
Rev Gr TTM
Revenue Growth TTM
-7.18%
PAT Gr TTM
PAT Growth TTM
321.28%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
12131212131312111312119
Growth YoY
Revenue Growth YoY%
-4.49.4-5.310.910.6-2.60.9-8.8-2.8-3.1-7.5-17.1
Expenses
ExpensesCr
11121112121211111111119
Operating Profit
Operating ProfitCr
111021102110
OPM
OPM%
4.56.58.20.712.58.68.5-0.214.79.36.5-5.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
011021102100
Tax
TaxCr
000000400000
PAT
PATCr
011011-301100
Growth YoY
PAT Growth YoY%
155.9-32.593.9348.550.8-727.850.0-5.4-24.8103.0-350.0
NPM
NPM%
2.75.24.4-0.711.18.0-27.5-0.410.86.20.9-2.0
EPS
EPS₹
0.50.90.7-0.12.01.4-4.6-0.11.90.90.1-0.2
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
12131212131312111312119
Growth YoY
Revenue Growth YoY%
-4.49.4-5.310.910.6-2.60.9-8.8-2.8-3.1-7.5-17.1
Expenses
ExpensesCr
11121112121211111111119
Operating Profit
Operating ProfitCr
111021102110
OPM
OPM%
4.56.58.20.712.58.68.5-0.214.79.36.5-5.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
011021102100
Tax
TaxCr
000000400000
PAT
PATCr
011011-301100
Growth YoY
PAT Growth YoY%
155.9-32.593.9348.550.8-727.850.0-5.4-24.8103.0-350.0
NPM
NPM%
2.75.24.4-0.711.18.0-27.5-0.410.86.20.9-2.0
EPS
EPS₹
0.50.90.7-0.12.01.4-4.6-0.11.90.90.1-0.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
252529313825404748504746
Growth
Revenue Growth%
-5.61.214.77.021.0-32.959.416.62.54.6-5.4-7.2
Expenses
ExpensesCr
252529313728394947464442
Operating Profit
Operating ProfitCr
00001-31-21443
OPM
OPM%
0.70.31.11.61.8-11.02.8-4.62.67.77.97.2
Other Income
Other IncomeCr
000001000000
Interest Expense
Interest ExpenseCr
000000011000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000-31-31333
Tax
TaxCr
0000000-10411
PAT
PATCr
-10000-31-20-122
Growth
PAT Growth%
-838.297.81,928.559.7-36.1-1,012.5134.6-291.6114.6-501.9325.0321.3
NPM
NPM%
-2.7-0.10.91.40.7-10.02.2-3.60.5-1.94.64.6
EPS
EPS₹
-0.90.00.10.60.4-3.41.2-2.30.3-1.32.92.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
252529313825404748504746
Growth
Revenue Growth%
-5.61.214.77.021.0-32.959.416.62.54.6-5.4-7.2
Expenses
ExpensesCr
252529313728394947464442
Operating Profit
Operating ProfitCr
00001-31-21443
OPM
OPM%
0.70.31.11.61.8-11.02.8-4.62.67.77.97.2
Other Income
Other IncomeCr
000001000000
Interest Expense
Interest ExpenseCr
000000011000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000-31-31333
Tax
TaxCr
0000000-10411
PAT
PATCr
-10000-31-20-122
Growth
PAT Growth%
-838.297.81,928.559.7-36.1-1,012.5134.6-291.6114.6-501.9325.0321.3
NPM
NPM%
-2.7-0.10.91.40.7-10.02.2-3.60.5-1.94.64.6
EPS
EPS₹
-0.90.00.10.60.4-3.41.2-2.30.3-1.32.92.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777778
Reserves
ReservesCr
3333401-10-12
Current Liabilities
Current LiabilitiesCr
76779121317121311
Non Current Liabilities
Non Current LiabilitiesCr
88222365444
Total Liabilities
Total LiabilitiesCr
2424191923222729232325
Current Assets
Current AssetsCr
151310912121516111214
Non Current Assets
Non Current AssetsCr
1011101011101212121110
Total Assets
Total AssetsCr
2424191923222729232325
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777778
Reserves
ReservesCr
3333401-10-12
Current Liabilities
Current LiabilitiesCr
76779121317121311
Non Current Liabilities
Non Current LiabilitiesCr
88222365444
Total Liabilities
Total LiabilitiesCr
2424191923222729232325
Current Assets
Current AssetsCr
151310912121516111214
Non Current Assets
Non Current AssetsCr
1011101011101212121110
Total Assets
Total AssetsCr
2424191923222729232325

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
005-1-2000332
Investing Cash Flow
Investing Cash FlowCr
001000-11000
Financing Cash Flow
Financing Cash FlowCr
-10-502220-4-30
Net Cash Flow
Net Cash FlowCr
-100-10101-212
Free Cash Flow
Free Cash FlowCr
005-1-2-1-30332
CFO To PAT
CFO To PAT%
-23.9-1,629.11,689.5-141.8-575.46.5-50.8-1.61,067.6-312.677.9
CFO To EBITDA
CFO To EBITDA%
98.7302.11,415.6-126.2-232.65.9-39.7-1.2205.278.845.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
005-1-2000332
Investing Cash Flow
Investing Cash FlowCr
001000-11000
Financing Cash Flow
Financing Cash FlowCr
-10-502220-4-30
Net Cash Flow
Net Cash FlowCr
-100-10101-212
Free Cash Flow
Free Cash FlowCr
005-1-2-1-30332
CFO To PAT
CFO To PAT%
-23.9-1,629.11,689.5-141.8-575.46.5-50.8-1.61,067.6-312.677.9
CFO To EBITDA
CFO To EBITDA%
98.7302.11,415.6-126.2-232.65.9-39.7-1.2205.278.845.8

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5109755191239452428
Price To Earnings
Price To Earnings
32.815.717.122.2160.410.913.1
Price To Sales
Price To Sales
0.20.40.30.20.10.20.50.30.80.90.50.6
Price To Book
Price To Book
0.51.00.80.60.40.72.31.85.57.42.52.9
EV To EBITDA
EV To EBITDA
72.7208.625.914.810.5-3.122.0-8.134.011.76.08.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.957.858.658.159.856.357.757.562.360.862.262.2
OPM
OPM%
0.70.31.11.61.8-11.02.8-4.62.67.77.97.2
NPM
NPM%
-2.7-0.10.91.40.7-10.02.2-3.60.5-1.94.64.6
ROCE
ROCE%
0.91.95.15.25.3-17.37.5-15.411.153.829.129.1
ROE
ROE%
-6.5-0.12.64.02.5-32.910.2-24.43.4-16.022.622.6
ROA
ROA%
-2.8-0.11.42.21.2-11.53.2-5.91.1-4.39.09.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5109755191239452428
Price To Earnings
Price To Earnings
32.815.717.122.2160.410.913.1
Price To Sales
Price To Sales
0.20.40.30.20.10.20.50.30.80.90.50.6
Price To Book
Price To Book
0.51.00.80.60.40.72.31.85.57.42.52.9
EV To EBITDA
EV To EBITDA
72.7208.625.914.810.5-3.122.0-8.134.011.76.08.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.957.858.658.159.856.357.757.562.360.862.262.2
OPM
OPM%
0.70.31.11.61.8-11.02.8-4.62.67.77.97.2
NPM
NPM%
-2.7-0.10.91.40.7-10.02.2-3.60.5-1.94.64.6
ROCE
ROCE%
0.91.95.15.25.3-17.37.5-15.411.153.829.129.1
ROE
ROE%
-6.5-0.12.64.02.5-32.910.2-24.43.4-16.022.622.6
ROA
ROA%
-2.8-0.11.42.21.2-11.53.2-5.91.1-4.39.09.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Gujarat Terce Laboratories Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/wcmzenocb6q3zxinc8j70fxw.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/cwzqgqnkykeuz56bqzm583fy.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/7mu6ccj3gdg2h1xvorqs60wz.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ehe6mhtj2e74z1ru6hagempf.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/vwutxm35rdns4f6v1kpnh9h4.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ofbux9bu3j2rdbl0vbo9ktxn.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/9270poamg87262ugfnylun5g.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/h1144zpkqmlnblo0i82pja3q.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/m7oq93a5p70256gcjpe13o2k.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/qv7oznxpwuu0l6r8xohejo56.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/8gn6ml2u4aqhmr0d41x33sh8.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/gtozel8v1n2s17ey9gzf9ncd.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/epby20uiygervlgvssj0qkv5.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/7w0i87sqf6c1g4fey5ah70sh.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/0tvuwiwa5aie8whm4g1v7tap.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/lclvnwil2ltq7lgst2gz5ag8.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/qpnrhcvrwc8lrs3arlom6ens.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/b4kwvkh5d9nj7u66iiz6jqiy.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/496jxuslrty9nh1i2saynjcl.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/m2nvzfhnpn0xxf8vn95bk3t4.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/id11xfjvnqkrwwgze5svk38a.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/va240y0unzc91sc5wqhzyh80.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies